Contribute Try STAT+ Today

In a move directed at the owners of Purdue Pharma, a pair of Democratic lawmakers has introduced a bill that would prevent people who have not filed for bankruptcy from being released from lawsuits brought by local communities or the U.S. government.

The legislation follows controversy over the bankruptcy plan filed last week by the drug maker. If the plan is approved by a federal bankruptcy court, some members of the Sackler family, who own Purdue, would receive immunity from the nearly 3,000 lawsuits filed by states, counties, cities and tribes seeking compensation for the costs of the opioid crisis. The drug maker filed for bankruptcy in September 2019.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.